Clinical trial
Glucose Regulation During Risperidone and Olanzapine Treatment
NCT00205738 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glucose Regulation During Risperidone and Olanzapine Treatment
- Lead sponsor
- Washington University School of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2000
- Completion date
- October 31, 2006
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schizophrenia, type 2 diabetes mellitus